Capricor Therapeutics, Inc.

CAPR Nasdaq SEC CIK 1133869
Follow Capricor Therapeutics Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Net income −$42.7M −73.6% vs same quarter last year
EPS, diluted −$0.73 −35.2% vs same quarter last year
Operating cash flow −$35.7M −81.3% vs same quarter last year
Operating income −$44.7M −70% vs same quarter last year
Net income by quarter
−$7.1M
−$24.4M
−$25.9M
−$24.6M
−$30.2M
−$33.9M
−$40.7M
−$42.7M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$150M−$100M−$50M$0$50MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$0−$105M
FY24$22.3M−$40.5M
FY23$25.2M−$22.3M
FY22$2.6M−$29M
FY21$244.9K−$20M
FY20$310.3K−$13.7M
FY19$1M−$7.6M
FY18$1.7M−$15.2M
FY17$2.7M$2.4M
FY16$4M−$18.8M
FY15$5.5M−$12.9M
FY14$4.8M−$6.2M
FY13$503.2K−$8.9M
FY12$195.5K−$2.1M
FY11$1.4M−$1.1M
MarginsShare of revenue
  • Operating margin
  • Net margin
−10000%−7500%−5000%−2500%0%2500%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearOperating marginNet margin
FY25--
FY24−191.1%−181.7%
FY23−95.6%−88.5%
FY22−1163.9%−1137.4%
FY21−8549.9%−8175.9%
FY20−4412.6%−4401.9%
FY19−769.5%−760.4%
FY18−917%−908.9%
FY17−482.4%91.2%
FY16−424.6%−470.3%
FY15−228.6%−233%
FY14−125.7%−129.9%
FY13−1371.7%−1767%
FY12−1074.2%−1059.5%
FY11−361.7%−84.9%
Free cash flowOperating cash flow minus capital expenditure
−$80M−$60M−$40M−$20M$0$20MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$72.7M
FY24−$41.2M
FY23−$26.9M
FY22$2.9M
FY21−$18M
FY20−$10.6M
FY19−$6.8M
FY18−$14.2M
FY17−$14.3M
FY16−$14.6M
FY15−$10.9M
FY14$795.9K
FY13−$6.2M
FY12−$2.2M
FY11−$4.7M
Returned to shareholdersDividends paid and shares bought back
$0$50$100$150$200FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearBuybacks
FY25-
FY24-
FY23-
FY22-
FY21-
FY20$0
FY19$193
FY18$0
FY17-
FY16-
FY15-
FY14-
FY13-
FY12-
FY11-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Capricor Therapeutics
  • Healthcare median
−10000%−7500%−5000%−2500%0%2500%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearCapricor TherapeuticsHealthcare median
FY25-−30.6%
FY24−181.7%−47%
FY23−88.5%−58%
FY22−1137.4%−80.4%
FY21−8175.9%−71.8%
FY20−4401.9%−62.2%
FY19−760.4%−46.2%
FY18−908.9%−49.6%
FY1791.2%−45.9%
FY16−470.3%−36%
FY15−233%−37.8%
FY14−129.9%−35.5%
FY13−1767%−37.1%
FY12−1059.5%−29.1%
FY11−84.9%−27.9%